Technical Analysis for RCEL - Avita Medical Limited
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | -2.53% | |
| NR7 | Range Contraction | -2.89% | |
| NR7-2 | Range Contraction | -2.89% | |
| Narrow Range Bar | Range Contraction | -2.89% | |
| Inside Day | Range Contraction | -2.89% | |
| Oversold Stochastic | Weakness | -2.89% | |
| NR7 | Range Contraction | -2.89% | |
| Doji - Bullish? | Reversal | -2.89% |
| Alert | Time |
|---|---|
| Down 3% | about 5 hours ago |
| Down 2 % | about 8 hours ago |
| 60 Minute Opening Range Breakdown | about 9 hours ago |
| Fell Below Previous Day's Low | about 9 hours ago |
| Down 1% | about 9 hours ago |
Get a Trading Sidekick!
- Earnings date: 08/08/2024
Avita Medical Limited Description
Avita Medical Limited operates as a regenerative medicine company in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients 18 years and older. The company has a preclinical research collaboration with the University of Colorado School of Medicine to establish and explore development of a spray-on treatment for patients with epidermolysis bullosa. The company is based in Valencia, California.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine Rare Diseases Clinical Research Dermatology Wound Suspension Regenerative Medicine Platform Technology Burns Genodermatoses Aesthetics Epidermolysis Bullosa Skin Chronic Wound Chronic Wounds Treatment Solutions
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 21.704 |
| 52 Week Low | 7.51 |
| Average Volume | 261,991 |
| 200-Day Moving Average | 12.46 |
| 50-Day Moving Average | 8.57 |
| 20-Day Moving Average | 8.52 |
| 10-Day Moving Average | 8.02 |
| Average True Range | 0.51 |
| RSI (14) | 34.64 |
| ADX | 19.78 |
| +DI | 15.56 |
| -DI | 24.03 |
| Chandelier Exit (Long, 3 ATRs) | 8.77 |
| Chandelier Exit (Short, 3 ATRs) | 9.19 |
| Upper Bollinger Bands | 9.66 |
| Lower Bollinger Band | 7.38 |
| Percent B (%b) | 0.15 |
| BandWidth | 26.74 |
| MACD Line | -0.34 |
| MACD Signal Line | -0.30 |
| MACD Histogram | -0.0416 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 8.37 | ||||
| Resistance 3 (R3) | 8.42 | 8.26 | 8.26 | ||
| Resistance 2 (R2) | 8.26 | 8.10 | 8.23 | 8.22 | |
| Resistance 1 (R1) | 7.99 | 7.99 | 7.91 | 7.94 | 8.19 |
| Pivot Point | 7.83 | 7.83 | 7.79 | 7.80 | 7.83 |
| Support 1 (S1) | 7.56 | 7.67 | 7.48 | 7.51 | 7.25 |
| Support 2 (S2) | 7.40 | 7.56 | 7.37 | 7.22 | |
| Support 3 (S3) | 7.13 | 7.40 | 7.18 | ||
| Support 4 (S4) | 7.08 |
